Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment

INTRODUCTION: In December 2019, an outbreak of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began, resulting in a number of antivirals and immune modulators being repurposed to treat the associated coronavirus disease 2019 (COVID-19). Many patients requiring treatment for COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Marra, Fiona, Smolders, Elise J., El-Sherif, Omar, Boyle, Alison, Davidson, Katherine, Sommerville, Andrew J., Marzolini, Catia, Siccardi, Marco, Burger, David, Gibbons, Sara, Khoo, Saye, Back, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745756/
https://www.ncbi.nlm.nih.gov/pubmed/33336316
http://dx.doi.org/10.1007/s40268-020-00333-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745756/
https://www.ncbi.nlm.nih.gov/pubmed/33336316
http://dx.doi.org/10.1007/s40268-020-00333-0

Ejemplares similares